Idiopathic pulmonary fibrosis (IPF), the most common and lethal form of lung scarring, has an outcome similar to that of lung cancer, with average survival of less than three years from diagnosis. To date, routinely available therapies have not been shown to improve survival. So, there is an urgent need for new, more effective treatments. [click link for full article]
(more...)